Children with asthma experienced fewer exacerbations and better control with dupilumab regardless of the duration of their ...

In two trials for sleep-related breathing diseases, a software platform analyzed nightly sleep metrics from a ring pulse ...

The likelihood for avoidance of five clinically important outcomes in patients with COPD and type 2 inflammation was greater with dupilumab vs. placebo, according to findings from a win ratio analysis ...